Updated Jul 16, 2026
Oki Mark K is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $146K.
Mark K. Oki is the Chief Financial Officer of Achieve Life Sciences, Inc., a specialty pharmaceutical company focused on developing cytisinicline for smoking cessation. He has been involved in the company's financial operations as indicated by his role and SEC filings.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-09-18 | ACHV | ACHIEVE LIFE SCIENCES, INC. | S — Open-market sale | 50.1K | $2.92 | $146K |
| 2025-09-18 | ACHV | ACHIEVE LIFE SCIENCES, INC. | M — Option exercise | 168.0K | $0.00 |
Mark K. Oki is the Chief Financial Officer of Achieve Life Sciences, Inc., a specialty pharmaceutical company focused on developing cytisinicline for smoking cessation. He has been involved in the company's financial operations as indicated by his role and SEC filings.…
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($146K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Oki Mark K profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.